Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653)

PURPOSE: Patients with metastatic urothelial carcinoma are often ineligible for cisplatin-based treatments. A National Cancer Institute Cancer Therapy Evaluation Program–sponsored trial assessed the tolerability and efficacy of a gemcitabine-eribulin combination in this population. METHODS: Patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Sadeghi, Sarmad, Groshen, Susan G., Tsao-Wei, Denice D., Parikh, Rahul, Mortazavi, Amir, Dorff, Tanya B., Kefauver, Cheryl, Hoimes, Christopher, Doyle, Laurence, Quinn, David I., Newman, Edward, Lara Jr, Primo N.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7006847/
https://ncbi.nlm.nih.gov/pubmed/31390274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00861
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados